Cumberland Pharmaceuticals Inc. Inventory, Work in Process and Raw Materials, Net of Reserves
Cumberland Pharmaceuticals Inc. (CPIX) had Inventory, Work in Process and Raw Materials, Net of Reserves of $9.68 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves · last filed 2026-08-07
- 2026-06-30: Inventory, Work in Process and Raw Materials, Net of Reserves $9.68M.
- 2026-03-31: Inventory, Work in Process and Raw Materials, Net of Reserves $10.06M.
- 2025-12-31: Inventory, Work in Process and Raw Materials, Net of Reserves $9.83M.
- 2025-09-30: Inventory, Work in Process and Raw Materials, Net of Reserves $9.75M.
| Period end | Inventory, Work in Process and Raw Materials, Net of Reserves |
|---|---|
| 2026-06-30 | $9.68M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $10.06M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $9.83M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $9.75M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $10.38M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $10.83M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $11.98M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $12.31M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $12.68M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $12.77M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $12.62M 10-Q · filed 2024-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |